Robert Steven Davidson - 22 Jul 2022 Form 4 Insider Report for Cure Pharmaceutical Holding Corp. (AVRW)

Reporting relationship: Director
Issuer ticker: AVRW
Reported as of: 22 Jul 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Aug 2022, 18:29:40 UTC
Prior SEC filing: 24 May 2021
Next SEC filing: 13 Sep 2022
Source filing: View source filing
Reporting owner signature: /s/ Joel M. Bennett, attorney-in-fact for Robert Steven Davidson

Key filing fact

Robert Steven Davidson filed Form 4 for Cure Pharmaceutical Holding Corp. (AVRW) on 22 Aug 2022.

Key facts

This page summarizes Robert Steven Davidson's Form 4 filing for Cure Pharmaceutical Holding Corp. (AVRW).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Aug 2022, 18:29.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

Shares, units, or other non-derivative securities reported in this filing.

AVRW transaction

Award

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 2 footnotes

Footnote F1

This late filing is due to an inadvertent administrative error and not any error of the Reporting Person.

Footnote F2

These shares of Common Stock were granted to the Reporting Person pursuant to the Issuer's 2017 Equity Incentive Plan.

SEC remarks

Exhibit 24 - Power of Attorney